Haas S
Institut für Experimentelle Chirurgie, Technischen Universität München.
Z Kardiol. 1993;82 Suppl 2:77-80.
The most commonly used therapy of thromboembolism consists of continuous intravenous infusions of heparin followed by a treatment with oral anticoagulants. A new aspect of this classical therapy is the possibility of subcutaneous administrations of heparin b.i.d. and, that heparin may be replaced by low molecular weight heparins. The therapy with low molecular weight heparins can be further simplified by only single daily injections and doses regimens which are adjusted to the patient's body weight and which do not require an individual laboratory monitoring.
血栓栓塞最常用的治疗方法是持续静脉输注肝素，随后口服抗凝剂进行治疗。这种经典疗法的一个新特点是肝素可以每日两次皮下注射，而且肝素可以被低分子量肝素替代。低分子量肝素治疗可以进一步简化为仅每日单次注射，且剂量方案根据患者体重调整，无需进行个体化实验室监测。
